JACKSONVILLE, FL, Sept. 20, 2022 (GLOBE NEWSWIRE) — Blockchain Moon Acquisition Corp. (“BMAC”) (Nasdaq: BMAQ) announces that on September 14, 2022, John P. Hopkins and Carl J. Johnson have been appointed to the Board of Directors as new independent directors.
“We are pleased to have added two highly experienced directors to the board as independent directors. Their experiences as directors, officers and consultants will benefit the shareholders of Blockchain Moon Acquisition Corp. greatly benefit,” commented Enzo Villani, Chairman and CEO of BMAC.
Mr. Hopkins has over 40 years of experience in accounting, finance and operations, turnarounds, acquisitions and divestitures, debt restructuring and information technology. Most recently, Mr. Hopkins was President and Chief Executive Officer of Professional Security Broadband Inc., a privately held provider of integrated security, managed services and business intelligence systems to Fortune 500 companies. As President and Chief Executive Officer, he was responsible for organic revenue growth from $18 million in 2012 to $75 million in 2021 and drove the development of PSB Exero, an industry-revolutionary private cloud-based business intelligence -Tool that provides NIST-level system documentation and cyber defenses for security. Mr. Hopkins began his career at the accounting firm PricewaterhouseCoopers, where he rose to the rank of Audit Manager. Mr. Hopkins then served in the roles of senior manager of ARCO Chemical Company, vice president of finance for Cambrex Corporation, chief financial officer of Measurement Specialties, Inc. and chief financial officer of Henry Brothers Electronics (NASDAQ: HBE). Mr. Hopkins also has extensive experience developing scalable enterprise automation platforms and leading business and accounting process reengineering and turnarounds. In addition to his leadership career, Mr. Hopkins served on the Board of Directors of Professional Security Broadband Inc. from 2011-2021 and on the Advisory Board of Felician University School of Business from 2019-2021. He is also a member of the American Institute of Chartered Accountants. In addition, Mr. Hopkins currently teaches at New York University Leonard N. School of Business, Seton Hall University Stillman School of Business, Seton Hall University School of Law and previously at Felician University School of Business. Mr. Hopkins holds an MBA from Villanova University and a bachelor’s degree in accounting from West Chester University.
Mr. Johnson has over 40 years of consumer healthcare marketing and sales experience. In 2019, Mr. Johnson founded Four Peaks Insight, LLC, a business development and executive coaching firm. He is also currently a member of ExecHQ, an executive consulting firm. Previously, Mr. Johnson served as President and Chief Executive Officer and a member of the Board of Directors of Entia Biosciences, Inc., a clinical-stage biotechnology company engaged in the development of pharmaceutical-grade organic compounds, from August 2015 to November 2017. Mr. Johnson served as President and Chief Executive Officer and member of the Board of Directors of Matrixx Initiatives, Inc., a marketer of over-the-counter (“OTC”) healthcare products, from July 2001 to October 2008, and again as a member of the Board of Directors of Matrixx Initiatives from February 2011 through February 2014. From 1993 to 2001, Mr. Johnson was Vice President, Commercial Development at The Perrigo Company, a leading manufacturer of OTC pharmaceutical and nutritional products for the private label market. Prior to that, Mr. Johnson held a number of senior marketing and sales positions at Johnson & Johnson from 1973 to 1989, including the position of VP Marketing & Sales at Vistakon, a Johnson & Johnson company. He also held the position of director of marketing for Johnson & Johnson Baby Products Company. Before joining Johnson & Johnson, Mr. Johnson was an account manager at Compton Advertising and oversaw Procter & Gamble. Mr. Johnson served on the Board of Directors of Scolr Pharma, Inc. from 2010 to 2013, including as Chairman from 2011 to 2013. Mr. Johnson also previously served on the boards of the Generic Pharmaceutical Association and the Consumer Healthcare Products Association. Mr. Johnson holds a Masters of Business Administration – Marketing from Fairleigh Dickinson University and a Bachelor of Science in Economics from Wagner College.
The Board of Directors of BMAC has affirmed that Mr. Hopkins and Mr. Johnson each meet applicable standards of independence under the rules of The Nasdaq Stock Market LLC.
It is expected that in connection with their appointment to the Board of Directors, Mr. Hopkins and Mr. Johnson will each enter into BMAC’s standard form of directors’ and officers’ indemnity agreement and affiliation agreements to be bound by the same provisions of that particular insider letter agreement, dated October 18, 2021, by and between BMAC and all officers, directors and original shareholders of BMAC.
About Blockchain Moon Acquisition Corp.
BMAC is a blank check corporation formed for the purpose of effecting a business combination of one or more companies. While there is no restriction or limitation as to what industry or geographic region the target company operates in, BMAC intends to pursue potential targets that are high growth blockchain technology companies in North America, Europe and Asia. Proceeds from the offering will be used to fund such a business combination. The BMAC team consists of investors and executives from the blockchain industry, including Enzo Villani, Chairman and CEO, Wes Levitt, Chief Financial Officer, and board members John Jacobs, Michael Terpin, James Haft, David Shafrir, and John P. Hopkins CarlJJohnson. Visit www.BMAQ.io for more information.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including the successful completion of BMAC’s initial public offering and the search for an initial business combination, are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements. BMAC expressly disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statements contained herein to reflect any change in BMAC’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
CONTACT: Sandra Ditore Partner Alpha Sigma Capital Email: sditore (at) alphasigma.fund